Evidence map›Paper›PMID 27909171›Full record

ArticleJournal of psychopharmacology (Oxford, England)2016

Psilocybin for depression and anxiety associated with life-threatening illnesses.

John D McCorvy, Reid Hj Olsen, Bryan L Roth

Abstract readComment
PubMed Publisher
In one paragraph

Article in Journal of psychopharmacology (Oxford, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

John D McCorvyDepartment of Pharmacology, Division of Chemical Biology and Medicinal Chemistry and the National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina Chapel Hill Medical School, Chapel Hill, NC, USA.
Reid Hj OlsenDepartment of Pharmacology, Division of Chemical Biology and Medicinal Chemistry and the National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina Chapel Hill Medical School, Chapel Hill, NC, USA.
Bryan L RothDepartment of Pharmacology, Division of Chemical Biology and Medicinal Chemistry and the National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina Chapel Hill Medical School, Chapel Hill, NC, USA bryan_roth@med.unc.edu.

Funding

Regulation of Adult Hippocampal Neurogenesis by Cholecystokinin-Expressing InterneuronsF31NS093917 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI OLSEN, REID HANS JOHNSON · 2015 to 2017
$103k
NINDS NIH HHS F31 NS093917
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DepressionPsilocybinAnxietyDepressive DisorderHallucinogensHumansHallucinogensPsilocybin

Identifiers

PMID27909171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.